ClariVest Asset Management’s Edwards Lifesciences EW Stock Holding History

ClariVest Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7	Closed	–	–	906
2023 Q3	$0	Buy	+7	New	+$563	﹤0.01%	784
2021 Q1	–	Sell	-9	Closed	-$1K	–	755
2020 Q4	$1K	Hold	9	–	–	﹤0.01%	679
2020 Q3	$1K	Hold	9	–	–	﹤0.01%	671
2020 Q2	$1K	Hold	9	–	–	﹤0.01%	734
2020 Q1	$1K	Hold	9	–	–	﹤0.01%	651
2019 Q4	$1K	Hold	9	–	–	﹤0.01%	608
2019 Q3	$1K	Hold	9	–	–	﹤0.01%	625
2019 Q2	$1K	Hold	9	–	–	﹤0.01%	603
2019 Q1	$1K	Hold	9	–	–	﹤0.01%	663
2018 Q4	$0	Sell	9 -885,399	-100%	-$44.8M	﹤0.01%	717
2018 Q3	$51.4M	Sell	885,408 -63,204	-7%	-$3.09M	0.91%	22
2018 Q2	$46M	Sell	948,612 -72,300	-7%	-$3.37M	0.8%	33
2018 Q1	$47.5M	Sell	1,020,912 -26,760	-3%	-$1.16M	0.82%	32
2017 Q4	$39.4M	Sell	1,047,672 -69,216	-6%	-$2.54M	0.68%	43
2017 Q3	$40.7M	Sell	1,116,888 -48,648	-4%	-$1.86M	0.94%	24
2017 Q2	$45.9M	Sell	1,165,536 -35,820	-3%	-$1.31M	1.12%	15
2017 Q1	$37.7M	Sell	1,201,356 -139,725	-10%	-$4.37M	0.94%	22
2016 Q4	$41.9M	Sell	1,341,081 -7,500	-0.6%	-$243K	1.12%	16
2016 Q3	$54.2M	Sell	1,348,581 -40,470	-3%	-$1.52M	1.57%	10
2016 Q2	$46.2M	Sell	1,389,051 -7,191	-0.5%	-$246K	1.38%	17
2016 Q1	$41.1M	Sell	1,396,242 -129,600	-8%	-$3.58M	1.24%	24
2015 Q4	$40.2M	Sell	1,525,842 -17,400	-1%	-$452K	1.14%	27
2015 Q3	$36.6M	Buy	+1,543,242	New	+$37.2M	1.1%	28

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ClariVest Asset Management's EW Position: Q4 2023 in Review

ClariVest Asset Management sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 7 shares.

ClariVest Asset Management first reported a position in EW in Q3 2015 and held it in 23 quarters. The position peaked at $54.2M in Q3 2016. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

ClariVest Asset Management reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
ClariVest Asset Management sold 7 Edwards Lifesciences shares in Q4 2023.
ClariVest Asset Management first reported a position in Edwards Lifesciences in Q3 2015 and held it in 23 quarters.
ClariVest Asset Management's Edwards Lifesciences position peaked at $54.2M in Q3 2016.
1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on ClariVest Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.